Jump to content
  • Sign Up
Scott Adams

Biolinerx (Blrx) Enrolls First Patient In Bl-7010 Phase 1/2 As Celiac Treatment - Streetinsider.com (Subscription)

Rate this topic

Recommended Posts

BioLineRx (BLRX) Enrolls First Patient in BL-7010 Phase 1/2 as Celiac Treatment

StreetInsider.com (subscription)

BioLineRx (Nasdaq: BLRX) announced enrollment of the first patient in a Phase 1/2 trial of BL-7010, for the treatment of celiac disease. The first patient was enrolled at Tampere Hospital in Finland, a world-leading site for celiac disease research ...

View the full article

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...